2022
Naltrexone-Bupropion and Behavior Therapy, Alone and Combined, for Binge-Eating Disorder: Randomized Double-Blind Placebo-Controlled Trial
Grilo CM, Lydecker JA, Fineberg SK, Moreno JO, Ivezaj V, Gueorguieva R. Naltrexone-Bupropion and Behavior Therapy, Alone and Combined, for Binge-Eating Disorder: Randomized Double-Blind Placebo-Controlled Trial. American Journal Of Psychiatry 2022, 179: 927-937. PMID: 36285406, PMCID: PMC9722598, DOI: 10.1176/appi.ajp.20220267.Peer-Reviewed Original ResearchConceptsBehavioral weight loss therapyBinge-eating disorderPlacebo groupBupropion groupWeight lossRandomized double-blind placebo-controlled trialDouble-blind placebo-controlled trialLogistic regressionBinge-eating remissionPlacebo-controlled trialWeight loss therapyDouble-blind placeboSerious public health problemPublic health problemEvidence-based treatmentsRate of participantsBinge-eating frequencyBinge Eating DisorderMedical comorbiditiesRemission rateLoss therapyPercent weight lossMixed modelsFunctional impairmentSecondary measures
2016
Development and preliminary effectiveness of an innovative treatment for binge eating in racially diverse adolescent girls
Mazzeo SE, Lydecker J, Harney M, Palmberg AA, Kelly NR, Gow RW, Bean MK, Thornton LM, Tanofsky-Kraff M, Bulik CM, Latzer Y, Stern M. Development and preliminary effectiveness of an innovative treatment for binge eating in racially diverse adolescent girls. Eating Behaviors 2016, 22: 199-205. PMID: 27299699, PMCID: PMC4983205, DOI: 10.1016/j.eatbeh.2016.06.014.Peer-Reviewed Original ResearchConceptsDiverse adolescent girlsAdolescent girlsDialectical behavior therapyDisorder cognitionsPsychological functioningNegative affectPsychological constructsControl eatingBehavior therapyDietary restraintWeight management groupPreliminary effectivenessBingeIntervention feasibilitySensitive treatmentSatisfaction measuresParticipantsBlack girlsPreliminary outcomesGirlsInterventionCognitionAffectEatingAdolescents